Plain-English translation of NCT06383182 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is tracking blood markers — special proteins and substances in your blood — in patients who receive emergency endovascular therapy, a minimally invasive procedure to remove blood clots from the brain during acute stroke. Researchers want to understand which blood markers can help predict how well patients will recover after this treatment, since about half of patients don't achieve the best possible outcomes even after successful clot removal.
While clot-removal surgery is highly effective for treating large vessel strokes, doctors still cannot reliably predict which patients will have good recovery and which will have lasting disability. This study aims to identify blood markers that could help doctors better understand each patient's prognosis and potentially guide future treatment decisions.
You likely qualify if…
You likely don't qualify if…
As a participant, you would receive the standard emergency clot-removal surgery for your stroke. During and after your treatment, researchers will collect blood samples at specific time points to measure biomarkers. You will need to allow for a neck vein catheter to be placed safely. Your participation involves providing these blood samples as part of a registry study tracking how your blood chemistry changes after treatment.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
China
Sponsor
General Hospital of Shenyang Military Region
Enrollment target
~800 participants
Started
July 2024
Primary completion
December 2027
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in September 2026.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.